A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Effect of RBT-1 on Preconditioning Response Biomarkers in Subjects Undergoing Coronary Artery Bypass Graft (CABG) and/or Cardiac Valve Surgery (the START Study).

  • Marasco, Silvana (Primary Chief Investigator (PCI))
  • Smith, Julian (Chief Investigator (CI))
  • Bennetts, Jayme S (Chief Investigator (CI))
  • Provenzano, Sylvio (Chief Investigator (CI))
  • Lyers, Anand (Chief Investigator (CI))

Project: Research

Project Details

Effective start/end date22/02/2131/12/24


  • Cardiothoracic Surgery
  • Clinical trial